Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Medicare

Eli Lilly Crushed Novo In Obesity Drug Battle—Trump Now Forces Price Cuts

President Donald Trump unveiled a major pricing and coverage deal with drug giants Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) on Thursday, pledging to make blockbuster weight-loss drugs like Zepbound and Wegovy significantly cheaper and accessible for millions of Americans.

Benzinga

Michael Burry Abandons UnitedHealth Stock With Shares Down 35% YTD. Should You Sell UNH or Buy the Dip?

Down almost 50% from all-time highs, UnitedHealth stock trades at a compelling valuation while offering investors an attractive dividend yield.

Barchart

Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx

President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Trump announces plan to cut cost of weight loss drugs and expand access

Injectable versions of GLP-1s from Eli Lilly and Novo Nordisk will see reduced prices and broader coverage

The Guardian - US

Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic

America's waistline may shrink, but its national debt will swell.

Fortune

How to Appeal a Medicare Denial (And Win): A Step-by-Step Guide

You open the mail, and your stomach drops. The Medicare Summary Notice shows a service or item as “Denied.” It’s infuriating and, additionally, very scary. Many people simply give up and pay the bill. However, a denial is *not* the end of the road. You have the right to appeal,…

Budget and the Bees

Trump says Medicare can now cover weight loss drugs like Ozempic

The pilot program could make it easier for seniors to use drugs like Wegovy and Zepbound.

Axios

Read news from The Economist, FT, and more,
with one subscription

Trump announces plans to slim down cost of popular weight-loss drugs to $149 a month

Novo Nordisk and Eli Lilly become latest drug companies to bend knee to Trump’s ‘most-favored nation’ pricing plan

The Independent UK

Trump unveils deal to expand coverage and lower costs on obesity drugs

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy

The Independent UK

Hidden Costs in Medicare Part C That Will Catch Seniors Off-Guard in 2026

What seems like a low-cost alternative to Original Medicare can come with financial surprises. Recent reports show that Medicare Advantage (Part C) enrollees may see...

Saving Advice

Trump is weaponizing the welfare state to attack healthcare

The proposed withholding of Medicaid and Medicare to restrict gender-affirming care follows the same logic as attacks on abortion care

The Guardian - US

I Tried a New AI Tool to Answer One of the Hardest Retirement Questions We All Face

As a veteran financial journalist, I tried the free AI-powered platform, Waterlily. Here's how it provided fresh insights into my retirement plan — and might help you.

Kiplinger

Parents and Caregivers: Don't Miss Your Roth Conversion Window

Caring for a child or parent can mean a drop in income and a lower tax bracket. Why not take advantage by moving money into a Roth account? Here's how it works.

Kiplinger

The Forgotten Grocery Benefit Hidden Inside Certain Health Plans

If you’re enrolled in a Medicare Advantage plan or certain private health insurance programs, you might be missing out on a surprising perk: free groceries....

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Less Than 1 In 5 Vanguard 401(k) Participants Are Using A Roth 401(k), Suze Orman Says 'That Is Nuts'

If you have a 401(k) through work, there's a chance your employer offers a Roth 401(k) option — and it's becoming more common. According to Vanguard, 86% of their 401(k) plans included a Roth feature at the end of 2024. That's up from 74% just four years earlier. Among larger…

Benzinga

Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles

Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82.

inkl

Navigating Australia's Dual Health System

Australia has a unique and complete healthcare system that is often called a "dual system." Medicare is the main part of it

Saving Advice

How to Qualify for Free Vision Exams Without Switching Insurance

Most people assume they need to switch insurance plans to get free vision care, but that’s not always true. Many existing plans—including Medicare Advantage, Medicaid,...

Get all your
news in one place.

100's of premium titles.
One news app.

Saving Advice

How Retirees Are Quietly Finding Free Dental Care Through Community Networks

Dental care is one of the most overlooked—and expensive—parts of retirement. Medicare doesn’t cover routine dental services, and private plans often come with high premiums...

Saving Advice

The Overlooked Medicare Supplement That Covers What Regular Plans Ignore

Medicare is a lifeline for millions of retirees—but it doesn’t cover everything. From dental and vision to long-term care and foreign travel, gaps in coverage...

The Independent UK

Trump team is negotiating with weight-loss drug makers to lower prices to $149 a month: report

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that purpose

Axios

Trump close to deal to allow Medicare coverage of weight loss drugs

A deal could significantly expand seniors' access to the popular drugs.

Benzinga

Eli Lilly, Novo Nordisk Stocks Rise on Reported $149 Obesity Drug Deal with White House

Eli Lilly and Company (NYSE:LLY) shares are in the spotlight following reports indicating the company is close to finalizing a White House agreement to provide its lowest-dose obesity medications at $149 per month, which could open the door to Medicare coverage and broader reimbursement options.

The Free Financial Advisor

11 Social Security Surprises That Hit You After Losing a Spouse

The loss of a spouse creates one of the most difficult life situations because it produces intense emotional suffering and major financial difficulties. Social Security serves as a vital financial resource, providing essential support to individuals who need its benefits as they transition between life stages. The Social Security rules…

The Guardian - AU

Many GPs ‘nervous’ about bulk-billing rollout under new Medicare scheme

Royal Australian College of General Practitioners says doctors concerned at being ‘100% reliant on government funding decisions’

1 … 29 30 31 32

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.